Stay updated on Pembrolizumab with Radiation in Hodgkin Lymphoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab with Radiation in Hodgkin Lymphoma Clinical Trial page.
Latest updates to the Pembrolizumab with Radiation in Hodgkin Lymphoma Clinical Trial page
- Check7 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.1%
- Check14 days agoChange DetectedThe study status has changed from 'Recruiting' to 'Active, not recruiting', and the contact details for study inquiries have been updated to provide new information on where the study is taking place.SummaryDifference7%
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedSeveral key resources related to lymphoma and rare diseases have been removed, including links to MedlinePlus and NIH, which may impact access to important health information.SummaryDifference4%
- Check35 days agoChange DetectedNew resources related to lymphoma and Hodgkin lymphoma have been added, including links to MedlinePlus, NIH, and DailyMed, which may provide valuable information for users interested in these conditions.SummaryDifference0.5%
- Check43 days agoChange DetectedThe website has been updated to version v2.12.2, adding new features for downloading data in various formats and selecting specific fields, while the previous version v2.12.1 has been removed.SummaryDifference4%
- Check50 days agoChange DetectedThe website has been updated from version v2.12.0 to v2.12.1.SummaryDifference0.1%
Stay in the know with updates to Pembrolizumab with Radiation in Hodgkin Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with Radiation in Hodgkin Lymphoma Clinical Trial page.